Australian Clinical Labs Limited (ACL.AX)
AUD 3.06
(7.37%)
AUD 3.06
(7.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 181.83 Million AUD | -8.26% |
| 2023 | 184.93 Million AUD | -51.81% |
| 2022 | 372.74 Million AUD | 95.18% |
| 2021 | 196.67 Million AUD | 98.69% |
| 2020 | 116.3 Million AUD | 2278.67% |
| 2019 | 3.92 Million AUD | -27.38% |
| 2018 | 5.4 Million AUD | 167.12% |
| 2017 | -8.05 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 82.52 Million AUD | 423.69% |
| 2024 FY | - AUD | 6.14% |
| 2024 Q3 | 22.91 Million AUD | -71.29% |
| 2024 Q1 | 15.24 Million AUD | -82.07% |
| 2024 Q4 | 22.91 Million AUD | 0.0% |
| 2023 Q4 | 84.06 Million AUD | 365.87% |
| 2023 FY | - AUD | -51.81% |
| 2023 Q3 | 18.04 Million AUD | -81.13% |
| 2023 Q1 | 21.2 Million AUD | -84.94% |
| 2023 Q2 | 95.62 Million AUD | 350.91% |
| 2022 Q2 | 239.29 Million AUD | 141.62% |
| 2022 Q1 | 99.03 Million AUD | -13.38% |
| 2022 FY | - AUD | 95.18% |
| 2022 Q4 | 140.78 Million AUD | 218.96% |
| 2022 Q3 | 44.13 Million AUD | -81.56% |
| 2021 FY | - AUD | 98.69% |
| 2021 Q3 | 37.04 Million AUD | -63.58% |
| 2021 Q2 | 101.71 Million AUD | 217.34% |
| 2021 Q4 | 114.33 Million AUD | 208.67% |
| 2021 Q1 | 32.05 Million AUD | -39.94% |
| 2020 Q2 | 41.93 Million AUD | 590.17% |
| 2020 FY | - AUD | 2278.67% |
| 2020 Q4 | 53.36 Million AUD | 498.98% |
| 2020 Q3 | 8.91 Million AUD | -78.75% |
| 2020 Q1 | 6.07 Million AUD | 0.0% |
| 2019 FY | - AUD | -27.38% |
| 2018 FY | - AUD | 167.12% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BCAL Diagnostics Limited | -5.66 Million AUD | 3308.735% |
| Genetic Signatures Limited | -20.33 Million AUD | 994.055% |
| Genetic Technologies Limited | -11.43 Million AUD | 1690.741% |
| Healius Limited | -298.09 Million AUD | 160.997% |
| Imagion Biosystems Limited | -13.69 Million AUD | 1427.56% |
| Integral Diagnostics Limited | 12.33 Million AUD | -1374.242% |
| INOVIQ Ltd | -6.63 Million AUD | 2841.18% |
| Microba Life Sciences Limited | -22.8 Million AUD | 897.2% |
| Monash IVF Group Limited | 13.02 Million AUD | -1296.031% |
| Rhythm Biosciences Limited | -6.79 Million AUD | 2775.63% |
| Sonic Healthcare Limited | 1.65 Billion AUD | 89.042% |